Journal Information Content Entity Continuant Continuant Entity Entity Periodical Generically Dependent Continuant Collection 2025-06-25T03:19:43 RDF description of Diabetes care - http://knowledgebase.healthpartners.com/individual/journal-issn-0149-5992 Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1) Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic registry Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial Redesigning primary care to improve diabetes outcomes (the UNITED Study) Simulated physician learning program improves glucose control in adults with diabetes Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative Thiazolidinediones: the case for early use Relationship between average glucose levels and HbA1c differs across racial groups: a substudy of the GRADE randomized trial Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [review] Comparison of insulin glargine 300 units/mL and 100 units/mL in adults with type 1 diabetes: continuous glucose monitoring profiles and variability using morning or evening injections Strategies to reduce the cost of renal complications in patients with type 2 diabetes [editorial] Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry National standards for diabetes self-management education [review] A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes Racial differences in and prognostic value of biomarkers of hyperglycemia Response to Comment on Powers et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics [editorial] Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011 Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial Is patient readiness to change a predictor of improved glycemic control? 2017 National standards for diabetes self-management education and support [review] Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry 2016 Health Care & Education presidential address: if DSME were a pill, would you prescribe it? Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial Limitations in achieving glycemic targets from CGM data and persistence of severe hypoglycemia in adults with type 1 diabetes regardless of insulin delivery method Lower glucose variability and hypoglycemia measured by continuous glucose monitoring with novel long-acting insulin LY2605541 versus insulin glargine Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery Continuous glucose monitoring in adults with type 1 diabetes with 35 years duration from the DCCT/EDIC Study No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes Insulin dose and cardiovascular mortality in the ACCORD Trial REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial Weight gain was associated with worsening glycemia and cardiovascular and kidney outcomes in patients with type 2 diabetes independent of diabetes medication in the GRADE randomized controlled trial Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group [review] Use of an automated device for alternative site blood glucose monitoring Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea Depression in adults in the T1D Exchange Clinic Registry 0149-5992 Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring The growing importance of diabetes screening [editorial] Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the Diabetes Control and Complications Trial Care management processes important for high-quality diabetes care Improving diabetes care in practice: findings from the TRANSLATE trial Diabetes management in correctional institutions Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study Safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes: from injections to hybrid closed-loop therapy One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial Trends in insulin use and diabetes control in the U.S.: 1988-1994 and 1999-2012 [editorial] Baseline characteristics of the Vitamin D and type 2 Diabetes (D2d) study: a contemporary prediabetes cohort that will inform diabetes prevention efforts Randomized trial of quality improvement intervention to improve diabetes care in primary care settings Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes Simulated physician learning intervention to improve safety and quality of diabetes care: a randomized trial Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes The Glucose Management Indicator: time to change course [editorial]? Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes National standards for diabetes self-management education Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers! Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis The use of rescue insulin in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020 Differential treatment effects on beta-cell function using model-based parameters in type 2 diabetes: results from the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes Continuous glucose monitoring-derived data report-simply a better management tool [editorial] Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review] International consensus on use of continuous glucose monitoring [review] Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia New insulin Glargine 300 Units/mL versus Glargine 100 Units/mL in people with type 1 diabetes: a randomized, phase 3a, open-label clinical trial (EDITION 4) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [review] American Diabetes Association. Standards of medical care in diabetes--2010 Diabetes Care Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes National standards for diabetes self-management education Diabetes Care Response to Comment on Lachin et al. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the Diabetes Control and Complications Trial. 2017;40:777-83 Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: The LixiLan-L randomized trial Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care National standards for diabetes self-management education [review] Response to Comment on Pathak et al. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011 Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants Diabetes and lung cancer among postmenopausal women Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes public The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading Diabetes care 3416 7805975 Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association [review] Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy . 2018;41:2275-2280 Diabetes Care Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association Diabetes Care Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial Racial/ethnic disparities in the prevalence of diabetes and prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) multisite cohort of adults in the U.S [editorial] A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes Duration of hybrid closed-loop insulin therapy to achieve representative glycemic outcomes in adults with type 1 diabetes [editorial] National standards for diabetes self-management education Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial Diabetes performance measures: current status and future directions Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [review] Validation of time in range as an outcome measure for diabetes clinical trials A joint venture with the commonwealth of independent states Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research Diabetes and cancer: a consensus report Continuous glucose monitoring in patients with type 1 diabetes using insulin injections [editorial] Glucose management indicator (GMI): insights and validation using Guardian 3 and Navigator 2 sensor data [editorial] Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes 1935-5548 Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [review] Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics [review article] Durability of addition of roux-en-Y gastric bypass to lifestyle intervention and nedical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: A randomized control trial New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2) Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial Increased mortality of patients with diabetes reporting severe hypoglycemia -cell function over time on glycemic outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): differential treatment effects of dual therapy Impact of insulin sensitivity and B Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in type 2 diabetes inadequately controlled on daily basal insulin: a phase 2 randomized controlled trial